EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 30-Apr-2025 20:08 ET (1-May-2025 00:08 GMT/UTC)

MIT engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors

Massachusetts Institute of Technology
Peer-Reviewed Publication

MIT researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The particles can be targeted directly to tumors, where they release their payload while avoiding many of the side effects of traditional chemotherapy.

Journal: Advanced Functional Materials
Funder: U.S. National Institutes of Health, Marble Center for Nanomedicine, Deshpande Center for Technological Innovation, Koch Institute Support (core) Grant from the National Cancer Institute

Promising drug discovery research gets funding boost from Ontario Institute for Cancer Research

Ontario Institute for Cancer Research
Grant and Award Announcement

The Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause fewer side effects and reduce the risk that cancer will come back.

Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds

American Cancer Society
Peer-Reviewed Publication

In 2022, the American Cancer Society (ACS) updated its nutrition and activity guidelines for cancer survivors, recommending they avoid obesity, stay physically active, eat a healthy diet, and limit alcohol intake. New research by ACS scientists shows a lifestyle aligned with these guidelines is associated with a lower mortality risk among non-smoking survivors of obesity-related cancers in the United States. Survivors who maintained a healthy lifestyle both before and after their diagnosis — or those who improved their habits after diagnosis — also had a lower mortality risk. The study is out today in the Journal of the National Cancer Institute.

Journal: JNCI Journal of the National Cancer Institute

Newfound role for cancer gene could improve key drug class

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

Journal: Nature
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Institutes of Health, NIH/National Institutes of Health

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

American Association for Cancer Research
Grant and Award Announcement

The 2025 AACR Award for Lifetime Achievement in Cancer Research will be presented to Rakesh K. Jain, PhD, Fellow of the AACR Academy, during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick Place Convention Center in Chicago, Illinois.

Meeting: AACR Annual Meeting 2025

USC Norris Comprehensive Cancer Center opens state-of-the-art Newport Beach Radiation Oncology and Imaging Center

University of Southern California - Health Sciences
Business Announcement

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC – Newport Beach Radiation Oncology and Imaging, a state-of-the-art radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach.

AI can recommend if you need to be screened for cancer

George Mason University
Peer-Reviewed Publication

Health care AI expert Farrokh Alemi highlights the underutilized power of predictive artificial intelligence to detect and prevent multiple common cancers.

Journal: Quality Management in Health Care

Call for papers: Special collection honoring Dr. Mikhail (Misha) Blagosklonny

Impact Journals LLC
Business Announcement

BUFFALO, NY — April 3, 2025 — Aging (Aging-US) is pleased to announce a special Call for Papers for a commemorative collection honoring the legacy of Dr. Mikhail (Misha) Blagosklonny, the founding editor of the journal and a pioneer in aging biology. His groundbreaking work shaped fundamental concepts in the field, particularly regarding the role of mTOR in aging and cancer, the use of rapamycin, bypassing senescence during the process of transformation, personalized medicine, and theories on why we age.

Reprogramming gut cells to treat short bowel syndrome

Weill Cornell Medicine
Peer-Reviewed Publication

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In a preclinical study, Weill Cornell Medicine investigators showed that the technique reversed the malnutrition that results when most of the small intestine is removed. The successful demonstration suggests that a similar strategy could be used to treat short bowel syndrome, a life-threatening disorder that can occur when very little of the small intestine remains after surgery to address chronic inflammation, cancer, trauma or congenital conditions.

Journal: Gastroenterology

Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer

University of Maryland School of Medicine
Peer-Reviewed Publication

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.

Journal: Cancer Research

33
34
35
36
37